A cluster randomised trial, cost-effectiveness analysis and psychosocial evaluation of insulin pump therapy compared with multiple injections during flexible intensive insulin therapy for type 1 diabetes: the REPOSE Trial
Health Technology Assessment2017Vol. 21(20), pp. 1–278
Citations Over TimeTop 10% of 2017 papers
Simon Heller, David White, Ellen Lee, Julia Lawton, Daniel Pollard, Norman Waugh, Stephanie A. Amiel, Katharine Barnard, Anita Beckwith, Alan Brennan, Michael J. Campbell, Cindy Cooper, Munyaradzi Dimairo, Simon Dixon, Daisy Elliott, Mark L. Evans, Fiona Green, Gemma Hackney, Peter Hammond, Nina Hallowell, Alan Jaap, Brian Kennon, Jackie Kirkham, Robert S. Lindsay, Peter Mansell, Diana Papaioannou, David Rankin, Pamela Royle, W Henry Smithson, Carolin Taylor
Abstract
This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 21, No. 20. See the NIHR Journals Library website for further project information.
Related Papers
- → Insulin pump therapy in children with type 1 diabetes: analysis of data from the SWEET registry(2016)124 cited
- → In Vitro Stability of Insulin Aspart in Simulated Continuous Subcutaneous Insulin Infusion Using a MiniMed® 508 Insulin Pump(2007)23 cited
- → Characteristics Associated With Diabetes Device Use Among Youth With Type 1 Diabetes(2021)1 cited
- Comparison of insulin pump and insulin aspart 30 in the treatment of newly diagnosed type 2 diabetes(2013)
- → 820-P: Faster-Acting Insulin Aspart vs. Insulin Aspart for Adults with Type 1 Diabetes Treated with Insulin Pump and Continuous Glucose Monitoring(2024)